RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 12 - per page Next page
Order by
MENOPUR(tm) , a highly purified formulation of natural hormones, is as effective and well tolerated as genetically engineered products for the treatment of infertility
"MENOPUR(tm) is at least as effective and well tolerated as genetically-engineered, so called recombinant FSH in women undergoing in-vitro fertilisation treatment" More
Questcor Signs Agreement With Beacon Pharmaceuticals to Market H.P. Acthar Gel in the United Kingdom
Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More
European Patent granted to APR Drug Delivery Technology for the preparation of granulates for stable aqueous dispersions of hydrophobic substances.
On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
STOWIC Ltd taken over by United Pharmaceuticals Ltd
STOWIC's IP and processes have been acquired by United Pharmaceuticals of Jordan. More
MOU Advances Breakthrough Implanting Technology
Collaborative agreement enhances access to new technology More
Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaboration Agreement
Collaborative agreement to discover and develop new drugs for the treatment of osteoporosis. More
Pheromone Sciences Signs Chinese Distribution Agreement
Fertility Monitor Definitive Distribution Deal More
Recombinant erythropoietin available: sufficient for the requirements of companies involved in new drug development or drug delivery system proof-of-concept testing
Dragon Pharmaceuticals offers surplus stocks of recombinant EPO (erythropoietin) More
FDA APPROVES BRAVELLE(tm) (urofollitropin for injection, purified)
FERRING'S NEW HUMAN-DERIVED FOLLICLE-STIMULATING HORMONE FOR INFERTILITY TREATMENT More
BioSante licenses hormone therapy technology
"Triple hormone therapy" patents cover novel combinations of estrogens and progestins with androgens, such as testosterone, which may have beneficial effects in women. More
Displaying 1..10 of 12 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Hormonal Contraceptives Market Forecast
Oct 2009 - $15,200
Major Depressive Disorder - Pipeline Review, Q1 2011
Feb 2011 - 91 pages - $500
Panic Disorder Therapy Area Pipeline Report
Nov 2010 - 102 pages - $1,495
Metabolic and Endocrinology Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Obsessive-Compulsive Disorder Therapy Area Pipeline Report
Nov 2010 - 117 pages - $1,495
Epidemiology: Autism Spectrum Disorders - Increasing recognition drives growth of treatable population
Feb 2011 - 42 pages - $5,700
Bipolar Disorder Therapy Area Pipeline Report
Nov 2010 - 251 pages - $1,495
Hypoactive Sexual Desire Disorder - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Epidemiology: Bipolar Disorders – Population growth to mean more patients with bipolar disorders
Jul 2011 - 39 pages - $5,700
Attention Deficit Disorder with Hyperactivity Therapy Area Pipeline Report
Nov 2010 - 297 pages - $1,495
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us